A Multi-Institutional Evaluation of Active Surveillance for Low Risk Prostate Cancer Academic Article uri icon

Overview

MeSH Major

  • Population Surveillance
  • Prostatic Neoplasms

abstract

  • With a median followup of 29 months active surveillance for select patients appears to be safe and associated with a low risk of systemic progression. Cancer at restaging biopsy and a higher total number of cancerous cores are associated with a lower likelihood of remaining on active surveillance. A restaging biopsy should be strongly considered to finalize eligibility for active surveillance.

publication date

  • April 2009

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4237227

Digital Object Identifier (DOI)

  • 10.1016/j.juro.2008.11.109

PubMed ID

  • 19233410

Additional Document Info

start page

  • 1635

end page

  • 41; discussion 1641

volume

  • 181

number

  • 4